Overall, the luminal-associated transcriptional programs (FOXA1-EHF-ITGB4) and its downstream ECM-receptor interaction pathway (SPP1, CD44, ITGB4) play a crucial role in IMA, influencing its immunity and tumor risk (Fig. 1A). This evidence concerns the gene EHF and neoplasm.